S&P 500 Futures
(0.05%) 5 520.00 points
Dow Jones Futures
(0.10%) 39 884 points
Nasdaq Futures
(0.16%) 19 782 points
Oil
(0.01%) $81.64
Gas
(0.46%) $2.82
Gold
(-0.34%) $2 336.40
Silver
(-0.05%) $29.51
Platinum
(0.27%) $1 004.50
USD/EUR
(0.02%) $0.932
USD/NOK
(0.01%) $10.53
USD/GBP
(0.01%) $0.788
USD/RUB
(-0.57%) $87.50

Aktualne aktualizacje dla Alaunos Therapeutics, [TCRT]

Giełda: NASDAQ Sektor: Healthcare Branża: Biotechnology
Ostatnio aktualizowano24 birž. 2024 @ 23:00

-3.84% $ 0.673

Live Chart Being Loaded With Signals

Commentary (24 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.49% compare to its pairs and should correct upwards.

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors...

Stats
Dzisiejszy wolumen 27 310
Średni wolumen 45 808
Kapitalizacja rynkowa 10.78M
EPS $-0.110 ( Q1 | 2024-05-15 )
Następna data zysków ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0200
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0150 (2.23%)
AADI 3.55%
ABCL -3.79%
ABCM 0.04%
ABEO -5.02%
ABIO -0.29%
ABOS -3.03%
ABSI 0.66%
ABUS 0.66%
ABVX 2.61%
ACAD 3.79%
ACER -17.95%
ACET 9.49%
ACGN 1.29%
ACHL 0.22%
ACHV -4.83%
ACIU 2.47%
ACLX -0.09%
ACRV -5.30%
ACST -0.31%
ACXP -2.15%
ADAG 0.69%
ADAP -1.06%
ADGI 0.87%
ADIL 2.68%
ADMA 0.09%
ADPT 1.54%
ADTX -2.08%
ADVM 1.63%
ADXN -5.75%
AEON -7.34%
AEZS -1.10%
AFMD 1.02%
AGEN 4.60%
AGIO 0.02%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -0.69%
AKRO 2.80%
AKTX -1.08%
AKUS 0.00%
ALBO 0.00%
ALDX -5.46%
ALEC 0.44%
ALGS -4.88%
ALKS -1.28%
ALLK 8.11%
ALLO 2.35%
ALLR -28.40%
ALNA 3.16%
ALNY 34.52%
ALPN 0.02%
ALPX 0.00%
ALRN -1.60%
ALT 11.39%
ALVR 4.92%
ALXN 0.00%
ALXO -0.15%
ALZN -7.26%
AMRN 2.72%
AMTI -3.13%
ANAB 0.21%
ANEB -1.49%
ANGN 0.00%
ANIX -0.79%
ANL 0.29%
ANNX -4.22%
ANPC -3.15%
APGE 2.63%
APGN 8.48%
APGNW 30.65%
APLM 9.95%
APLS 0.92%
APLT 1.76%
APM 1.73%
APOP 0.38%
APRE 3.24%
APTO -2.37%
APTX 3.17%
APVO 1.15%
ARAV -13.39%
ARCT -0.44%
ARDS 2.49%
ARDX 1.46%
ARGX 11.69%
ARNA 0.00%
ARPO -0.90%
ARQT 4.59%
ARTL -2.71%
ARTLW 0.00%
ARVN -0.99%
ARWR 6.82%
ASLN -2.99%
ASMB 0.38%
ASND 1.20%
ATAI 4.48%
ATHA 1.28%
ATHE 2.27%
ATHX -33.50%
ATNF 2.05%
ATOS -5.31%
ATRA 0.67%
ATXI 9.52%
ATXS -2.65%
AUPH 2.35%
AURA -1.25%
AUTL -2.87%
AVBP -0.78%
AVEO 0.00%
AVIR 1.45%
AVRO -1.41%
AVTE -3.85%
AVTX 2.99%
AVXL 3.19%
AXLA 0.00%
AXSM 2.76%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -15.94%
BCAB 3.31%
BCDA -5.67%
BCDAW -39.75%
BCEL 0.00%
BCLI 2.70%
BCRX -2.34%
BCTX -7.44%
BCTXW -18.26%
BCYC 0.10%
BDRX -15.63%
BDTX 0.83%
BEAM 8.24%
BFRA -2.91%
BGNE 1.95%
BIOR 1.50%
BIVI 0.96%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX 3.39%
BLTE 0.27%
BLU 0.03%
BLUE 13.45%
BMEA 5.51%
BMRN 1.62%
BNOX 2.99%
BNTC 4.80%
BNTX 2.33%
BOLD 13.42%
BOLT -1.45%
BPMC 1.79%
BPTH 0.88%
BPTS -13.47%
BRNS 0.00%
BRTX 1.72%
BTAI 4.39%
BTTX 0.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -1.78%
CABA -1.53%
CADL 1.82%
CALA 0.00%
CALC -1.87%
CALT 1.83%
CAPR 1.91%
CARA 22.71%
CARM 9.80%
CASI 7.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.40%
CCCC 11.08%
CCXI 0.00%
CDAK 0.00%
CDIO -0.17%
CDIOW 36.86%
CDMO -4.38%
CDMOP 0.04%
CDT -7.05%
CDTTW -23.91%
CDTX -2.84%
CDXC -6.59%
CDXS 2.04%
CELC 4.58%
CELU 0.66%
CELUW 11.18%
CERC -1.68%
CERE -0.55%
CERO 2.09%
CEROW -22.90%
CFRX -27.95%
CGEM -0.34%
CGEN -5.08%
CGON 1.50%
CGTX -2.63%
CHMA -6.00%
CHRS -2.40%
CINC 0.00%
CING 4.73%
CINGW 73.79%
CKPT 15.56%
CLBS -16.75%
CLDX 2.55%
CLGN 6.22%
CLLS 1.06%
CLNN -3.46%
CLNNW -33.25%
CLRB 0.00%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB 8.57%
CMND -7.59%
CMPI 0.00%
CMPX 0.91%
CMRA 0.00%
CMRAW 33.33%
CMRX 1.85%
CNCE 0.00%
CNSP 12.63%
CNST 0.00%
CNTA -2.31%
CNTB -6.25%
CNTX 0.93%
COCP -1.88%
COEPW 0.00%
COGT 1.14%
CORT 1.83%
COYA -2.48%
CPRX -1.28%
CRBP 2.42%
CRBU 8.72%
CRDF -3.67%
CRGX 4.50%
CRIS 3.02%
CRNX 0.18%
CRSP 3.02%
CRTX 2.63%
CRVO 0.40%
CRVS 2.81%
CSBR -1.20%
CTCX -7.84%
CTIC 0.06%
CTMX 3.10%
CTNM 3.23%
CTXR 4.68%
CUE 8.89%
CVAC 6.44%
CVKD 6.24%
CWBR 0.00%
CYAD -12.96%
CYCC -5.01%
CYCCP 4.03%
CYCN 6.69%
CYT -2.27%
CYTK 0.71%
CYTO 2.61%
DARE 1.96%
DAWN -1.10%
DBTX -0.81%
DBVT -1.80%
DFFN 10.28%
DICE 0.06%
DMAC 2.78%
DNLI 1.24%
DNTH -0.04%
DOMH -2.63%
DRMA 12.50%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.62%
DRTSW 0.00%
DRUG -3.77%
DSGN -0.59%
DTIL 0.85%
DYAI -9.66%
EARS -1.77%
EDIT -0.59%
EDSA -0.11%
EFTR -75.81%
EFTRW -96.33%
EIGR -9.21%
ELAB 0.86%
ELDN -4.40%
ELEV -4.30%
ELOX 0.00%
ELTX 6.89%
ELVN 1.87%
ELYM -8.69%
ENGN -9.67%
ENGNW -7.87%
ENLV 3.68%
ENOB 1.79%
ENSC 4.98%
ENTA 2.43%
ENTO -2.13%
ENTX 1.98%
ENVB 9.19%
EPIX -1.02%
EPRX 0.57%
EPZM 0.00%
EQ 2.52%
EQRX -2.09%
EQRXW 0.00%
ERAS 2.37%
ERNA -4.64%
ERYP 1.30%
ESLA -0.50%
ESLAW 0.00%
ETNB -0.82%
ETON -0.60%
ETTX 0.00%
EVAX -5.28%
EVGN -2.18%
EVLO 0.00%
EWTX -1.99%
EXAI -2.78%
EXEL 0.54%
EYEG 0.11%
EYEN 2.28%
EYPT 0.59%
FATE 2.13%
FBIO -3.95%
FBIOP 0.59%
FBLG 5.49%
FBRX 0.27%
FDMT 1.35%
FENC -1.09%
FGEN 6.19%
FHTX 0.38%
FIXX 0.77%
FMTX 0.00%
FNCH -6.77%
FOLD -0.89%
FREQ 4.76%
FRLN 0.15%
FRTX -4.51%
FSTX 0.00%
FTRE -0.65%
FULC -5.09%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -8.97%
GANX 0.00%
GBIO 1.45%
GBT 0.01%
GDTC 5.61%
GERN -1.29%
GHRS 0.42%
GLMD -1.83%
GLPG 1.67%
GLSI -4.73%
GLTO 5.51%
GLUE 4.96%
GLYC 3.61%
GMAB -0.81%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 1.29%
GNLX 10.68%
GNPX 0.00%
GNTA 7.74%
GOSS 27.09%
GOVX 30.04%
GOVXW 49.24%
GPCR -4.15%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 4.76%
GRTX 40.48%
GTHX -10.48%
GUTS 5.77%
GXGXW 41.67%
GYRE -3.28%
HALO 0.99%
HARP 0.09%
HCWB 10.69%
HEPA 5.42%
HGEN -84.62%
HILS 5.66%
HLVX 2.75%
HOOK -1.07%
HOTH 0.67%
HOWL -9.38%
HRMY -0.10%
HRTX -1.55%
HSTO 0.00%
HUMA -1.35%
HUMAW 5.19%
IBRX 1.10%
ICCC -0.22%
ICPT 0.21%
ICU 10.12%
ICUCW 14.68%
ICVX -0.91%
IDRA -23.04%
IDYA 0.03%
IFRX 8.44%
IGMS 0.00%
IKNA -2.33%
IKT -5.00%
IMAB 2.38%
IMCR -0.28%
IMGN 0.02%
IMGO 0.00%
IMMP -2.92%
IMMX 11.76%
IMNM -4.02%
IMNN -4.46%
IMPL -27.27%
IMRA 15.96%
IMRN 12.11%
IMRX 4.20%
IMTX -1.37%
IMTXW -14.50%
IMUX -0.90%
IMV 0.00%
IMVT 0.18%
INAB -0.84%
INBX 2.18%
INCY 0.84%
INDP -1.33%
INFI -52.38%
INKT -1.62%
INM 9.72%
INMB 1.62%
INO -1.61%
INSM 0.65%
INTS 4.74%
INVA 0.63%
INZY 0.67%
IOBT 0.00%
IONS 6.81%
IOVA 1.87%
IPA -1.92%
IPHA -5.16%
IPSC -6.29%
IRON 1.81%
ISEE 0.38%
ITOS 0.61%
ITRM -5.65%
IVA -0.71%
IVVD 2.42%
JAGX -3.32%
JANX 5.52%
JAZZ 1.72%
JNCE 0.00%
JSPR 1.72%
JSPRW 4.71%
JUNS 0.00%
JUNSW 0.00%
KA 13.13%
KALV -0.17%
KDNY 0.22%
KMPH -0.34%
KNSA 1.40%
KNTE -0.38%
KOD 3.41%
KPRX 9.68%
KPTI 12.76%
KRBP -0.40%
KRON -6.48%
KROS 0.09%
KRRO -0.76%
KRTX 0.03%
KRYS 1.97%
KTRA 6.15%
KTTA 4.85%
KTTAW -5.17%
KURA 0.67%
KYMR -1.69%
KYTX 2.07%
KZIA -15.51%
KZR 1.12%
LABP 0.57%
LBPH 0.05%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.13%
LENZ -1.52%
LEXX -1.49%
LEXXW -0.19%
LGND 0.72%
LGNDV 0.00%
LGVN -12.73%
LIAN -8.28%
LIFE 2.70%
LIPO 10.88%
LIXT -1.57%
LIXTW 0.00%
LJPC -0.32%
LMNL 0.12%
LOGC 1.27%
LPCN 3.56%
LPTX -2.08%
LQDA 3.28%
LRMR -10.33%
LSTA -3.26%
LTRN -5.78%
LUMO 1.79%
LVTX 0.27%
LXEO 4.94%
LXRX -2.16%
LYEL 3.41%
LYRA -2.78%
MACK 0.10%
MBIO 2.70%
MBRX -3.48%
MCRB -2.19%
MDGL 2.00%
MDNA -13.16%
MDWD 7.88%
MDXG -1.02%
MEIP -2.80%
MESO -3.28%
MGNX 2.97%
MGTA -7.74%
MGTX -3.18%
MGX 0.56%
MIRM 8.74%
MIRO 0.59%
MIST 0.72%
MITO 0.00%
MLEC -5.36%
MLECW 90.24%
MLND -5.36%
MLTX 0.73%
MLYS 4.90%
MNKD 6.26%
MNMD 0.27%
MNOV 0.00%
MNPR 15.76%
MOLN -25.10%
MOR -0.11%
MORF 10.26%
MREO -5.53%
MRKR 9.03%
MRNA 2.70%
MRNS 3.01%
MRSN 3.76%
MRTX -0.17%
MRUS 3.77%
MRVI -2.35%
MTCR -1.29%
MTEM -4.59%
MTP -18.50%
MURA -0.62%
MYMD -4.12%
NAMS 8.93%
NAMSW 26.87%
NAUT -8.57%
NBRV 0.71%
NBSE -1.56%
NBTX 4.81%
NCNA -0.34%
NERV -5.52%
NEXI -2.44%
NGM -1.28%
NGNE 2.39%
NKGN 0.00%
NKGNW 8.00%
NKTR 0.86%
NKTX 1.82%
NLSP -5.16%
NLSPW 28.30%
NMRA 0.00%
NMTR -42.97%
NOVN -24.84%
NRBO 0.49%
NRIX -1.27%
NRSN -3.99%
NRSNW 0.00%
NRXP 0.75%
NRXPW 0.00%
NRXS -0.78%
NTBL 0.36%
NTEC -12.45%
NTHI 0.00%
NTLA 3.22%
NTRBW 0.00%
NUVL 1.72%
NVAX 0.14%
NVCT 2.13%
NVIV -34.28%
NXTC 3.70%
NYMX -0.05%
OABI 1.75%
OABIW -3.65%
OBIO 9.02%
OBSV 0.00%
OCEA 7.75%
OCGN -5.26%
OCS 1.37%
OCUL 4.48%
OCUP 1.27%
ODT -4.27%
OKYO -1.63%
OLMA 2.15%
OMER 2.90%
OMGA -0.41%
ONCO -6.85%
ONCR -3.08%
ONCS 31.87%
ONCT -1.85%
ONCY 0.00%
ONTX -0.47%
ONVO -2.28%
OPNT 0.00%
OPT -4.93%
ORGS -3.25%
ORIC -1.11%
ORMP -3.04%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.62%
OVID 1.28%
OYST 0.00%
PALI -3.95%
PASG 0.00%
PBLA -4.76%
PBM -4.74%
PBYI -2.34%
PCSA 0.51%
PCVX 1.12%
PDSB 8.33%
PEPG 4.57%
PGEN 4.55%
PHAR 13.76%
PHAS 0.00%
PHAT -2.26%
PHIO 3.65%
PHIOW 36.47%
PHVS -4.62%
PHXM -5.20%
PIRS -5.56%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 3.28%
PLUR -0.44%
PMN -0.63%
PMVP 4.64%
PNT 0.16%
PPBT 5.78%
PRAX -2.61%
PRDS 0.93%
PRLD 2.88%
PROG -3.47%
PROK -7.60%
PRQR -3.51%
PRTA 0.56%
PRTC -6.90%
PRTG -0.04%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -11.11%
PSTX -1.08%
PTCT -2.05%
PTE -0.82%
PTGX -0.78%
PTIXW -5.10%
PULM -2.53%
PXMD 0.00%
PYPD -1.97%
PYXS -5.34%
QLGN -8.10%
QNCX 0.71%
QNRX 1.44%
QSI 0.84%
QSIAW 1.20%
QTTB -0.71%
QURE -1.09%
RAIN -1.63%
RANI -0.96%
RAPT 3.18%
RARE -0.45%
RCKT 7.03%
REGN 1.02%
RENB 1.27%
REPL 3.06%
RETA 0.02%
REUN -0.89%
REVB 13.74%
REVBU 3.46%
REVBW 50.29%
RGLS -18.33%
RGNX 6.41%
RIGL 0.65%
RLAY -0.58%
RLMD -0.99%
RLYB 5.48%
RNA 1.69%
RNAC 1.05%
RNAZ 5.27%
RNXT 4.09%
ROIV 2.06%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.74%
RPTX 0.28%
RUBY 2.70%
RVLP -32.05%
RVMD 0.76%
RVMDW 17.51%
RVNC -3.38%
RVPH 2.40%
RVPHW 1.92%
RXDX 0.09%
RXRX 5.54%
RYTM 1.58%
RYZB 0.02%
RZLT 7.85%
SABS 4.23%
SABSW -35.81%
SAGE 3.86%
SANA 0.54%
SAVA -1.10%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -6.67%
SCPH 1.24%
SCPS 0.00%
SEEL -2.49%
SEER 1.76%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 5.62%
SGMT 6.87%
SGTX -2.56%
SIOX 22.63%
SLDB 2.48%
SLGL 0.59%
SLN 3.61%
SLNO -2.60%
SLRX -3.97%
SLS -0.82%
SMMT 0.88%
SNDX -1.25%
SNGX -2.31%
SNPX 5.67%
SONN -6.53%
SPPI -0.49%
SPRB 5.39%
SPRC -2.42%
SPRO -2.92%
SRNE 15.79%
SRPT 1.95%
SRRA 0.00%
SRRK -0.47%
SRZN 5.26%
STAB 0.00%
STOK 0.70%
STRO -4.95%
STSA 0.00%
STTK -9.50%
SURF -0.93%
SVRA -5.67%
SWTX -0.17%
SYBX 2.01%
SYRS 4.12%
TALS -0.73%
TARA -1.33%
TARS 1.36%
TBPH 0.23%
TCBP -8.11%
TCDA 0.00%
TCON -1.60%
TCRR 0.00%
TCRT -3.84%
TCRX 2.92%
TECH 1.13%
TENX 9.03%
TERN 4.01%
TFFP 9.20%
TGTX 4.31%
THRX 0.12%
TIL -3.68%
TLC 0.00%
TLSA 14.49%
TNGX 0.50%
TNXP -8.46%
TNYA -0.96%
TPST 2.96%
TRDA -4.11%
TRVI -2.22%
TRVN -13.99%
TSHA -10.14%
TSVT 3.76%
TTNP -14.84%
TVTX 6.57%
TYRA 0.35%
UBX 0.36%
UNCY 7.44%
URGN 5.81%
UTHR 0.92%
VACC 11.36%
VALN 12.99%
VAXX -10.53%
VBIV 3.44%
VBLT -8.77%
VCEL 2.64%
VCNX -0.49%
VCYT 1.77%
VERA -2.79%
VERU 9.04%
VERV -0.19%
VIGL 0.52%
VINC -1.38%
VIR 0.22%
VIRI -1.85%
VIRX -5.63%
VKTX -1.18%
VLON -13.04%
VNDA -2.29%
VOR 4.20%
VRCA -4.56%
VRDN 5.09%
VRNA 4.60%
VRPX -4.95%
VRTX 1.33%
VSTM -1.90%
VTGN -3.58%
VTVT 0.00%
VTYX -0.80%
VXRT 5.82%
VYGR -0.43%
VYNE -4.95%
VYNT 7.78%
WINT 7.90%
WVE -0.76%
XBIO -5.83%
XBIT -12.02%
XCUR -3.35%
XENE -0.21%
XERS 0.00%
XFOR 0.00%
XLO 2.47%
XLRN 0.00%
XNCR 1.46%
XOMA 5.64%
XOMAO -0.20%
XOMAP -0.76%
XRTX -2.38%
YMAB 0.83%
ZGNX 0.00%
ZIOP -0.88%
ZLAB 0.97%
ZNTL -3.16%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-06 Weis Holger Buy 19 200 Employee Stock Option (right to buy)
2024-06-06 Weis Holger Buy 4 524 Employee Stock Option (right to buy)
2024-06-06 Vieser Jaime Buy 12 800 Employee Stock Option (right to buy)
2024-06-06 Postma Robert W Buy 12 800 Employee Stock Option (right to buy)
2024-06-06 Hofmeister Robert Buy 12 800 Employee Stock Option (right to buy)
INSIDER POWER
96.63
Last 87 transactions
Buy: 15 616 124 | Sell: 1 296 896
Korelacja (AI algo v.1.1b): Undervalued: 0.49% $0.676 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.05 (neutral)
Krótki: -0.42 (neutral)
Signal:(45.619) Neutral

Alaunos Therapeutics, Korelacja

10 Najbardziej pozytywne korelacje
OMEX0.832
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alaunos Therapeutics, Korelacja - Waluta/Towar

The country flag -0.07
( neutral )
The country flag -0.17
( neutral )
The country flag 0.00
( neutral )
The country flag 0.04
( neutral )
The country flag -0.14
( neutral )
The country flag -0.04
( neutral )

Alaunos Therapeutics, Finanse

Annual 2023
Przychody: $5 000.00
Zysk brutto: $-2.31M (-46 200.00 %)
EPS: $-2.20
FY 2023
Przychody: $5 000.00
Zysk brutto: $-2.31M (-46 200.00 %)
EPS: $-2.20
FY 2022
Przychody: $2.92M
Zysk brutto: $163 000 (5.58 %)
EPS: $-2.60
FY 2021
Przychody: $0.00
Zysk brutto: $0.00 (0.00 %)
EPS: $-0.370

Financial Reports:

No articles found.

Alaunos Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Alaunos Therapeutics,

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej

Total Execution Time: 1.4917860031128 seconds
Number of API calls: 3
Number of DB calls: 9